Genoa, Italy

Giuseppe Celasco

This inventor holds 8 USPTO granted patents and 9 published patent applications, plus 3 CIPO patents and 2 EPO patents. Top assignee: Cosmo Technologies Limited. Active years: 2012-2019.

USPTO Granted Patents = 8 

% Patents Active = 75.0


 

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovations of Giuseppe Celasco

Introduction

Giuseppe Celasco is a notable inventor based in Genoa, Italy. He has made significant contributions to the field of diagnostics, particularly in the development of solid compositions for oral administration of dyes. With a total of eight patents to his name, Celasco's work has the potential to impact medical diagnostics significantly.

Latest Patents

Celasco's latest patents include a solid composition for the oral administration of dyes and its diagnostic use. This application discloses solid compositions aimed at the diagnostic evaluation of the gastrointestinal tract. The innovative approach taken by Celasco in this area showcases his commitment to advancing medical technology.

Career Highlights

Giuseppe Celasco is currently associated with Cosmo Technologies Limited, where he continues to develop groundbreaking solutions in the field of diagnostics. His work has garnered attention for its potential applications in improving diagnostic procedures.

Collaborations

Celasco has collaborated with notable colleagues such as Mauro Ajani and Roberto Villa. These partnerships have likely contributed to the innovative nature of his work and the successful development of his patents.

Conclusion

Giuseppe Celasco's contributions to the field of diagnostics through his innovative patents highlight his role as a significant inventor. His work continues to pave the way for advancements in medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…